Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Extension of Pegvaliase in PKU
NCT00924703Phase 2Completed
- Sponsor
- BioMarin Pharmaceutical
- Start
- Jan 2010
- Primary completion
- Jan 2019
- Modality
- PEGylated Peptides, Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of pegvaliase in phenylketonuria (PKU), sponsored by BioMarin Pharmaceutical. Started Jan 2010; status: completed.
02
Drugs
pegvaliase
03
Conditions
phenylketonuria (PKU)
Beyond the preview
Go deeper on NCT00924703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00924703.